Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;50(11):3466-71.
doi: 10.1128/JCM.01685-12. Epub 2012 Aug 8.

Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test

Affiliations

Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test

Barbara Van Der Pol et al. J Clin Microbiol. 2012 Nov.

Abstract

Herpes infections are among the most common sexually transmitted infections (STI), but diagnostic methods for genital herpes have not kept pace with the movement toward molecular testing. Here, we describe an FDA-approved molecular assay that identifies and types herpes simplex virus (HSV) infections for use in routine clinical settings. Paired samples from anogenital lesions were tested using the BD ProbeTec HSV Q(x) (HSVQ(x)) system, HSV culture and, a laboratory-developed PCR assay. Family planning, obstetrics/gynecology (OB/GYN), or sexually transmitted disease (STD) clinics in the United States served as recruitment sites. Sensitivity and specificity estimates, head-to-head comparisons, measures of agreement, and latent-class analyses were performed to provide robust estimates of performance. A total of 508 participants (174 men and 334 women) with anogenital lesions were included; 260 HSV-2 and 73 HSV-1 infections were identified. No differences in test performance based on gender, clinic type, location of the lesion, or type of lesion were observed. The sensitivity of HSV-2 detection ranged from 98.4 to 100% depending on the analytical approach, while the specificity ranged from 80.6%, compared to the less sensitive culture method, to 97.0%, compared to PCR. For HSV-1, the sensitivity and specificity ranges were 96.7 to 100% and 95.1 to 99.4%, respectively. This assay may improve our ability to accurately diagnose anogenital lesions due to herpes infection.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Sample collection and testing scheme. UVT samples were aliquoted for use in all three HSV assays (Elvis culture, PCR, and HSVQx). HSV-1 testing in the Elvis system could be performed only on HSV-2-negative samples. The sample collected using the assay collection kit (Qx WS) and the UVT aliquoted into the collection kit were both tested on the HSVQx system. +, positive; −, negative.
Fig 2
Fig 2
Assay sensitivity by organism load for HSV-2. PCR-positive samples generated a viral-load value. The percent positivity of the other two assays (Elvis culture and HSVQx) for HSV-2 is shown based on the PCR-determined organism load.
Fig 3
Fig 3
Assay sensitivity by organism load for HSV-1. PCR-positive samples generated a viral-load value. The percent positivity of the other two assays (Elvis culture and HSVQx) for HSV-1 is shown based on the PCR-determined organism load.

Similar articles

Cited by

References

    1. Baeten JM, et al. 2008. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J. Infect. Dis. 198: 1804–1808 - PMC - PubMed
    1. Baughman AL, et al. 2008. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin. Vaccine Immunol. 15: 106–114 - PMC - PubMed
    1. Benedetti J, Corey L, Ashley R. 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121: 847–854 - PubMed
    1. Cattamanchi A, et al. 2008. Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system. Clin. Vaccine Immunol. 15: 1638–1643 - PMC - PubMed
    1. Centers for Disease Control and Prevention 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb. Mortal. Weekly Rep. 59: 1–112

Publication types